Genomic Medicine in Chronic Disease Management: The Moderating Role of Clinical Decision Support Technologies

Abstract

Genomic medicine has emerged as a transformative approach in chronic disease management, enabling personalized prevention, diagnosis, and treatment strategies. By leveraging genomic data, healthcare providers can identify individual susceptibility to chronic conditions such as cardiovascular disease, diabetes, and cancer, allowing for tailored interventions that optimize patient outcomes. Despite its potential, the integration of genomic medicine into clinical practice faces challenges, including data complexity, limited provider knowledge, and the need for effective interpretation of genomic information. Clinical decision support technologies (CDSTs), such as electronic health record-based alerts, genomic risk prediction tools, and AI-driven recommendation systems, can enhance the utility of genomic medicine by facilitating real-time, evidence-based clinical decision-making. This study examines the role of genomic medicine in chronic disease management and investigates the moderating effect of CDSTs on the relationship between genomic medicine implementation and patient health outcomes. Genomic medicine interventions include risk assessment, pharmacogenomics, and targeted therapeutic strategies. CDSTs provide actionable insights to clinicians, improving the translation of genomic data into individualized care. A quantitative research design was employed, collecting data through structured questionnaires from healthcare providers, genetic counselors, and clinical informatics specialists in multiple healthcare institutions. Smart PLS structural equation modeling was used to test the direct effects of genomic medicine on chronic disease management outcomes and the moderating effect of CDSTs. Findings indicate that genomic medicine significantly enhances chronic disease management outcomes. The presence of CDSTs strengthens this relationship by improving data interpretation, clinical workflow integration, and adherence to evidence-based recommendations. The study provides empirical evidence supporting the integration of genomic medicine with advanced clinical decision support to optimize chronic disease management. These findings have practical implications for healthcare administrators, policymakers, and clinical informatics teams seeking to implement precision medicine strategies effectively